Research ExplorerPublicationsPrimär solitäres malignes Schwannom des N. trigeminus. Fallb...

Primär solitäres malignes Schwannom des N. trigeminus. Fallbericht mit Literaturübersicht

Standard

Primär solitäres malignes Schwannom des N. trigeminus. Fallbericht mit Literaturübersicht. / Moeller, H C; Heiland, M; Vesper, M; Hellner, D; Schmelzle, R.

In: Mund Kiefer Gesichtschir, Vol. 3, No. 6, 01.11.1999, p. 331-4.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Moeller, HC, Heiland, M, Vesper, M, Hellner, D & Schmelzle, R 1999, 'Primär solitäres malignes Schwannom des N. trigeminus. Fallbericht mit Literaturübersicht', Mund Kiefer Gesichtschir, vol. 3, no. 6, pp. 331-4.

APA

Moeller, H. C., Heiland, M., Vesper, M., Hellner, D., & Schmelzle, R. (1999). Primär solitäres malignes Schwannom des N. trigeminus. Fallbericht mit Literaturübersicht. Mund Kiefer Gesichtschir, 3(6), 331-4.

Vancouver

Moeller HC, Heiland M, Vesper M, Hellner D, Schmelzle R. Primär solitäres malignes Schwannom des N. trigeminus. Fallbericht mit Literaturübersicht. Mund Kiefer Gesichtschir. 1999 Nov 1;3(6):331-4.

Bibtex

@article{9d5dbbfa7e4d4a08acd5607faf196cfd,
title = "Prim{\"a}r solit{\"a}res malignes Schwannom des N. trigeminus. Fallbericht mit Literatur{\"u}bersicht",
abstract = "We present the case of a primary solitary malignant schwannoma of the trigeminal nerve. A total of 55 cases have been described in the literature; however, in these cases two tumors were affecting the supraorbital branch. This nerve-sheath tumor usually affects men in the fifth decade of life. The main clinical sign of malignant schwannomas of the head and neck is an indolent swelling. Hematogenic or lymphogenic metastasis has not been described. Because of the pleomorphism of the tumor cells immunohistochemical study is important. The treatment of choice is radical resection, possibly with adjuvant radio- or chemotherapy. The 5-year survival rate of malignant schwannoma of the trigeminal nerve is 41.7%.",
keywords = "Aged, Combined Modality Therapy, Female, Head and Neck Neoplasms, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Male, Neoplasms, Nerve Tissue, Neurilemmoma, Postoperative Care, Survival Rate, Treatment Outcome, Trigeminal Nerve",
author = "Moeller, {H C} and M Heiland and M Vesper and D Hellner and R Schmelzle",
year = "1999",
month = nov,
day = "1",
language = "Deutsch",
volume = "3",
pages = "331--4",
number = "6",

}

RIS

TY - JOUR

T1 - Primär solitäres malignes Schwannom des N. trigeminus. Fallbericht mit Literaturübersicht

AU - Moeller, H C

AU - Heiland, M

AU - Vesper, M

AU - Hellner, D

AU - Schmelzle, R

PY - 1999/11/1

Y1 - 1999/11/1

N2 - We present the case of a primary solitary malignant schwannoma of the trigeminal nerve. A total of 55 cases have been described in the literature; however, in these cases two tumors were affecting the supraorbital branch. This nerve-sheath tumor usually affects men in the fifth decade of life. The main clinical sign of malignant schwannomas of the head and neck is an indolent swelling. Hematogenic or lymphogenic metastasis has not been described. Because of the pleomorphism of the tumor cells immunohistochemical study is important. The treatment of choice is radical resection, possibly with adjuvant radio- or chemotherapy. The 5-year survival rate of malignant schwannoma of the trigeminal nerve is 41.7%.

AB - We present the case of a primary solitary malignant schwannoma of the trigeminal nerve. A total of 55 cases have been described in the literature; however, in these cases two tumors were affecting the supraorbital branch. This nerve-sheath tumor usually affects men in the fifth decade of life. The main clinical sign of malignant schwannomas of the head and neck is an indolent swelling. Hematogenic or lymphogenic metastasis has not been described. Because of the pleomorphism of the tumor cells immunohistochemical study is important. The treatment of choice is radical resection, possibly with adjuvant radio- or chemotherapy. The 5-year survival rate of malignant schwannoma of the trigeminal nerve is 41.7%.

KW - Aged

KW - Combined Modality Therapy

KW - Female

KW - Head and Neck Neoplasms

KW - Humans

KW - Immunohistochemistry

KW - Magnetic Resonance Imaging

KW - Male

KW - Neoplasms, Nerve Tissue

KW - Neurilemmoma

KW - Postoperative Care

KW - Survival Rate

KW - Treatment Outcome

KW - Trigeminal Nerve

M3 - SCORING: Zeitschriftenaufsatz

C2 - 10643286

VL - 3

SP - 331

EP - 334

IS - 6

ER -